Search Results 431-440 of 17001 for Progeria
In patients with gastroesophageal reflux and/or laryngopharyngeal reflux with cricopharyngeal hypertrophy or Zenker's diverticulum, does cricopharyngeal myotomy ...
Mayo Clinic first in U.S. to test stem cell use in clinical trial for pediatric congenital heart disease. Mayo Clinic Staff. November 25, 2013.
About this study. To evaluate and compare the efficacy and safety of regorafenib versus placebo in subjects with colorectal cancer (CRC) after curative ...
Watch Mayo Clinic neurologist Ronald C. Petersen, M.D., Ph.D., talk about mild cognitive impairment on HBO — The Alzheimer's Project. Research Profiles. Edit ...
Learn about this common cancer, including information on prevention, symptoms, diagnosis and treatment.
Latest stories ; International. Mayo Clinic Forms Collaboration with Enterprise Ireland to Develop Novel Technologies. April 10, 2014 ; Health & Wellness. Mayo ...
The purpose of this study is to determine safety of plasma infusion in APOE 44 patients. Participation eligibility. Participant eligibility includes age, gender ...
Researchers revealed what appeared to be two separate health conditions stemmed from a single, shared genetic variant. Latest stories.
This is a first-in-human, open-label, dose-escalation, dose-optimization trial designed to evaluate the safety, tolerability, pharmacokinetics, pharmacodynamics ...
The purpose of this study is to assess the experience of pregnancy within selected populations of women with congenital heart disease (e.g.. Ebstein's anomaly).
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your gift to celebrate this day advances our doctors’ lifesaving work.